Esperion Sues Daiichi Sankyo Over $300M Milestone Payment

By PacConAdmin | March 28, 2023

Esperion is suing Daiichi Sankyo over a failure to pay a $300 million milestone payment for the cardiovascular drug Nexletol (bempedoic acid), a treatment for heterozygous familial hypercholesterolemia or established atherosclerotic cardiovascular disease.
Source: Drug Industry Daily

Posted in Drug Industry Daily